O XIII Congresso da Sociedade Brasileira de Biociências Nucleares – SBBN 2021 – aconteceu em paralelo com o 20th Congress of the International Union for Pure and Applied Biophysics (IUPAB), o 45th Annual Brazilian Society of Biophysics Meeting, e o 50th Annual Brazilian Society of Biochemistry Meeting, de 3 a 8 de outubro, compartilhando plataforma virtual 3D.
a) Apresentar pesquisas em bioquímica e biofísica para produtos para imagens moleculares, técnicas para terapias e dosimetria, inclusive experiências pré clinicas e clínicas. b) Apresentar técnicas analíticas nucleares, para reduzir o impacto ambiental e melhorar a qualidade da água, controle da poluição, e a proteção da biodiversidade, assim como o transporte sustentável de materiais radioativos e nucleares. c) Comparar o estado da técnica da Radiobiologia, com os levantamentos epidemiológicos, discutindo a percepção de risco (nuclear, radiológico, sanitário e ambiental) e comparando a atual estrutura regulatória com os novos paradigmas da Biologia.
Themes
Venue
Committee
Program
Key Dates
Rates
Registration
Abstract/Articles
Certificates
Themes
Radiation Biology, Epidemiology and Radiation Exposures (occupational, public, and medical)
Internal and external dosimetry (medical and industrial)
Climate changes, the natural occurrence of radioactive materials and waste management
Transport of nuclear and radioactive materials and equipment and its environmental impact
Nuclear analytical techniques
Potential and accidental exposures, biodosimetry, countermeasures, and medical management
Radioisotopes production in research nuclear reactors and cyclotrons
Nanomaterials, nanobiotechnology and nanotoxicity
Radiopharmaceuticals development, preclinical, translational modeling and clinical studies
Molecular imaging techniques, signaling processing, quality assurance and artificial intelligence
Radionuclide therapy and external radiotherapy, including proton therapy
Regulatory issues, education, employment, and science communication
Silvia Maria Velasques de Oliveira, D.Sc., SBBN President Marcelo Mamede, Ph.D., SBBN Vice President Valbert Nascimento Cardoso, D.Sc., SBBN Scientific Director Divanizia Nascimento Souza, D.Sc., SBBN Events and scientific diffusion Director Luciana Malavolta Quaglio, D.Sc., SBBN Secretary Fabio Luiz Navarro Marques, D.Sc., SBBN Treasurer Rodrigo Modesto Gadelha Gontijo, D.Sc., SBBN Second Secretary Adelia Sayhun, M.Sc., SBBN Second Treasurer
SCIENTIFIC COMMITTEE
Alessandro Facure, D.Sc. (Comissão Nacional de Energia Nuclear-CNEN) Ademir de Jesus Amaral, Ph.D. (Universidade Federal de Pernambuco) Bianca Gutfilen, D.Sc. (Faculdade de Medicina, Universidade Federal do Rio de Janeiro-FM/UFRJ) Claudia de Alencar Santos Lage, D.Sc. (Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro- IBCCF/UFRJ) Denison Souza Santos, D.Sc. (Instituto de Radioproteção e Dosimetria, IRD/CNEN) Désirée Zouain, D.Sc. (R2IBF Radiopharmaceuticals) Dunstana Melo. Ph.D. (Melohill Technology Inc., USA) Edson Ramos de Andrade, D.Sc. (Universidade Federal da Paraiba) Jean Remy D. Guimarães, D.Sc. (Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro- IBCCF/UFRJ) Priscilla Brunelli Pujatti, D.Sc. (Instituto Nacional do Cancer-INCA/MS) Simone Coutinho Cardoso, D.Sc. (Instituto de Física, Universidade Federal do Rio de Janeiro-IF/UFRJ) Sergio Augusto Lopes de Souza, D.Sc. (Faculdade de Medicina, Universidade Federal do Rio de Janeiro-FM-UFRJ)
Program
Symposium 1: The nuclear technologies: innovations for minimizing the environmental impact Chairs José A. Perrotta (IPEN/CNEN/SP, Brazil) and Viviana Canhao Coelho, Climate Change Executive Manager, Petrobras, Brazil)
• Non-electrical applications of nuclear energy (Leonam S. Guimarães, ELETRONUCLEAR President, Brazil) (22:34 min) • Deployment of Small Modular Reactors (SMR) and Transportable Nuclear Power Plants (TNPP) (Stephen Whittingham, Head of Transport Safety Unit, IAEA, Austria) (18:50 min) • Naturally occurrence of radioactive materials (NORM) in the mining and oil industry (Amenônia Pinto, CDTN/CNEN, Brazil) (17 min)
Keynote Lecture 1: The control of exposure to natural occurring radioactive materials (20 min video and 40 min live forum) Lecturer: Abel J. González (Autoridad Regulatoria Nuclear, Argentina) Chair: Adelia Sahyun (ATOMO, Brazil)
Symposium 2: Biochemistry and biotechnology for radiopharmaceuticals development Chair: Priscilla Pujatti (INCA, Brazil)
• New developments in imaging cell-based therapy (Jane Sosabowski, Barts Cancer Institute, Queen Mary University of London, UK) (33:10 min) • Radioisotopes and pharmaceuticals for positron emission tomography (PET) (Suzanne Lapi, Director U.A.B. Cyclotron, The University of Alabama at Birmingham, Alabama, USA) (16:57 min) • Global initiatives for diagnosis and therapy (theranostics) radiopharmaceuticals availability (Amir Jalilian, IAEA, Austria) (23 min)
Keynote Lecture 2: The Chernobyl Tissue Bank: a resource for radiation research Lecturer: Geraldine Thomas, OBE (Imperial College London, UK) Chair: Maria Paula Curado (A.C. Camargo Cancer Center, Brazil)
Symposium 4: Patients radiation exposures and epidemiological surveys Chair: Claudia Lage (UFRJ, Brazil)
• Subsequent neoplasm risk following childhood cancer (Lindsay M. Morton, National Cancer Institute-NCI-NIH, USA) (20:40 min) • The EPI-CT-a European cohort study to quantify cancer risks in paediatric and young adult patients from CT radiation (Ausrele Kesminiene, International Agency for research on Cancer-IARC/WHO, France) • Global surveillance of trends in cancer incidence and survival (M. P. Curado, A.C. Camargo Cancer Center, Brazil) (26:37 min)
Symposium 5: Development of models for tumoral and inflammatory imaging Chair: Daniele Faria (CMN-FM-USP, Brazil)
• Three-dimensional cellular culture system for testing of biological effects of radiations in tumoral and non-tumoral models (Daniel P. Vieira, IPEN/CNEN, Brazil) (15:04 min) • 131I-ixolaris as a theranostic (diagnostic and therapy) agent: metastatic melanoma preclinical studies (Sergio A. L. Souza, Medical School, UFRJ, CENABIO, Brazil) (14:10 min) • Derivative from the antimicrobial peptide LyeTx I as potential pósitron emission tomography (PET) radiopharmaceutical (Leonardo Fuscaldi, Santa Casa de São Paulo- SCSP, Brazil) (17:34 min) • Use of 99mTc-anti-TNF-alpha as a marker of inflammatory disease activity (Sergio A. L. Souza, Medical School, UFRJ, CENABIO, Brazil) (17:00 min) • Application of the 18F-FDG radiopharmaceutical in the detection of Chagas disease (Villarroel LF; Babi YA; Dos Santos SN; Da Silva JS; Bernardes ES. Nuclear and Energy Research Institute, São Paulo, Brazil; Faculdade de Medicina de Universidade de São Paulo de Ribeirão Preto, Brazil) (10 min)
Symposium 6: Radiotracers as signatures evaluating water quality and the biodiversity protection Chair: Jean Remy D. Guimarães (Biophysics Institute, UFRJ) • High uranium concentrations in the groundwater of the Rio de Janeiro State, Brazil, mountainous region (José M. Godoy, PUC-RJ, Brazil) (13:53 min) • Removal of Zn and Cd from overlying water by mangrove sediments: testing the effects of sediment resuspension (Wilson Machado, Universidade Federal Fluminense, Brazil) • Chemical diversity in tree species from Caatinga (Elvis França, CRCN/CNEN, Brazil) • Natural radionuclides and radiogenic isotopes and tracers of coastal marine sedimentation processes (Heitor Evangelista, LARAMG, UERJ, Brazil)
Keynote Lecture 3: Radiation biodosimetry: new paradigms
Lecturer: Sally Amundson (Columbia University, USA) Chair: Dunstana Melo (Melohill Technology, USA)
Symposium 7: Radiation occupational exposures Chair: Denison S. Santos (Instituto de Radioproteção e Dosimetria-IRD/CNEN, Brasil and International Commission on Radiological Protection-ICRP member)
• Mathematical tools for radiological protection and dosimetry (Denison S. Santos, IRD/CNEN, Brazil) (29:51 min) • Occupational exposure to ionizing radiation (Dunstana Melo, Melohill Technology, USA) (25:29 min) • Radiation protection from a laboratory service perspective (Yvone Mascarenhas, SAPRA Landauer, Brazil) (27:08 min)
Symposium 8: External radiation techniques for precision cancer therapy Chair: Ademir Amaral (UFPE, Brazil)
• Dose fractionation in radiotherapy patients (Helena Segreto, UNIFESP, SBRT, Brazil) (20:50 min) • Proton therapy to treat pediatric patients (Luis A. Perles, Texas University, USA) (19:20 min) • Postmastectomy radiation therapy: challenges on the ESTRO-ACROP consensus guideline (Divanizia Souza, Universidade Federal de Sergipe, Brazil) (19:43 min) • Biological dosimetry for predicting acute side effects in radiotherapy (Ademir Amaral, Universidade Federal de Pernambuco, Brazil) (21:00 min)
Symposium 9: Androgen receptors signaling for prostate cancer imaging and therapy Chair: Sergio Souza (UFRJ, Brazil)
• Androgen receptor and prostate cancer (Hernandes Carvalho, Biology Institute, UNICAMP, Brazil) (22:02 min) • Clinical trials with 18F-PSMA1007 (Cristina Matushita, PUC-RS, InsCer, SBMN, Brazil) (15:50 min) • Clinical applications of Positron Emission Tomography (PET) with 68Ga-PSMA (Lilian Yuri Itaya Yamaga, Hospital I. Albert Einstein, Brazil) (18:57 min) • Radionuclide therapy with 177Lu PSMA for prostate cancer (Euclides T. Rocha, Hospital do Cancer de Barretos, Brazil) (21:21 min)
Keynote Lecture 4: Particle Radiation Therapy: developments, studies and applications
Lecturer: Gustavo A. Santa Cruz (Comissión Nacional de Energia Atomica-CNEA, Argentina) Chair: Silvia Velasques (SBBN, Brazil)
Symposium 10: Molecular imaging in neurosciences Chair: Valbert N. Cardoso (UFMG, Brazil)
• Peripheral nervous system in the war against cancer (Alexander Birbrair, UFMG, Brazil) (20:45 min) • New trends in PET radiopharmaceuticals for neurological diseases: preclinical research in astrocytocis in Alzheimer Disease (Eduardo Savio, CUDIM, Uruguay) (15:55 min) • Temporal and spatial changes in cerebral blood flow in neuropsychiatric systemic Lupus Erythematosus: a subtraction brain SPECT study (Lauro Wichert-Ana, Ribeirão Preto Medical School, USP, Brazil) (20:11 min)
Symposium 11: Perspectives for innovations and the intersection between research and the health public attention (Discussion in Portuguese) Chair: Daniel Coiro (Santa Casa de Misericórdia da Bahia, ABFM, Brazil)
• Legal framework, scenarios and perspectives for technology innovations in Brazil (Gianna Sagazio, Confederação Nacional da Indústria-CNI, MEI, Brazil) (11:25 min) • Cyclotron products certified by a public hospital in São Paulo (Miriam Okamoto, CMN-FM-USP, Brazil) (19:10 min) • Growth and strengthening of the private sector in the Brazilian radiopharmaceutical market – the case of R2IBF (Désirée Zouain, IBFR2 Radiopharmaceuticals, Brazil) (17:34 min) • A public facility for alpha emitters production (Julio C. Suita, IEN/CNEN, Brazil) (21:37 min)
Symposium 12: Synchrotron Radiation in Biology and Medicine Chair: Simone Coutinho Cardoso (UFRJ, ABFM, Brazil)
• Synchrotron-based X-ray imaging and microspectroscopy applied to life sciences (Carlos Alberto Perez, CNPEM, Brazil) • Manganese as a central element in tumor progression (Mariana Paranhos Stelling, IFRJ, Brazil) (19:40 min) • Synchrotron X-ray biosample imaging (Regina Cely Barroso, UERJ, Brazil) (20:05 min) • Opportunities and challenges for achieving high-resolution in vivo tomographic images in animal systems (Murilo de Carvalho, CNPEM, Brazil) (20:41 min)
streaming: https://www.youtube.com/SBBNbiocienciasnucleares Keynote Lecture 5: Women in the nuclear field promoting Latin American integration (in Portuguese) Lecturer: Nelida Del Mastro (IPEN, Brazil) Chair: Silvia Velasques (SBBN President, Brazil)
Symposium 13: Multidisciplinar education and employment (In Portuguese and LIBRAS) Chair: Rodrigo Gadelha Gontijo (SBBN Jovem Coordinator, Brazil) Interviews with Marcio Alvarenga (Radio Universidade de Uberlândia, UFU, Brazil)
– Luciene Mota (Curso de Tecnologia em Radiologia da Faculdade de Medicina, UFMG, Brazil) – Denise Zezell (Mestrado profissional em saúde do IPEN/CNEN/SP, Brazil) – Priscilla Pujatti (Residência multiprofissional do Instituto Nacional do Câncer, Brazil) – Gustavo Rico Freitas (Gestor no Hospital Regional de Cotia, Serviço Estadual de Diagnóstico por Imagem, São Paulo, Brazil)
Key Dates
ATÉ 24 de setembro: última chance para registro regular – COM DIREITO A PARCELAMENTO NO CARTÃO DE CRÉDITO
Após 24 de setembro só serão aceitos pagamentos a vista (não haverá mais parcelamento) e poderá ser feito via pix, transferência bancária ou cartão de crédito. Entrar em contato com, [email protected] para solicitar mAIS informações.
Rates
SBM, SBF e ABFM pagam preços de associados da SBBN anexando no formulário de inscrições online declaração fornecida pela respectiva sociedade de que o associado está adimplente 2021.
Taxas de inscrições incluem: admissão a todas as sessões técnicas e salão de exibições, livro de resumos online, exibições técnicas virtuais e certificados de participação e apresentação de trabalhos online. Para palestrantes e avaliadores de trabalhos, a SBBN emitirá certificados que serão encaminhados por email aos interessados.
Cancelamento e devolução de inscrições
A inscrição não poderá ser transferida para outra pessoa. Se o inscrito não pode participar do congresso, sua inscrição deverá ser cancelada. O recibo do pagamento e a carta solicitando devolução da inscrição deve ser recebida antes de 01/08, dirigida para [email protected]. O reembolso será limitado a 70% da taxa de inscrição paga, para cobertura de despesas operacionais e taxas bancárias. Após 02/08/2021, nenhuma devolução será efetuada.
Registration
Ao acessar a área de inscrições online, é possivel acessar o evento e baixar o certificado de participação.
Artigos completos: Autores com resumos aprovados poderão publicar o artigo completo correspondente nos ANAIS DA SBBN sem custos e obedecendo ás instruções para auroes em https://sbbn.org.br/anais-sbbn/
Certificates
Downloads
Speakers
Gallery
Organized by
SBBN - Sociedade Brasileira de Biociências Nucleares
A Sociedade Brasileira de Biociências Nucleares (SBBN) é uma associação civil e sem fins lucrativos.
São associados pesquisadores, professores e tecnologistas (titulares) e estudantes de graduação, pós-graduação e pós-doutoramento (aspirantes), com formação em Ciências Biológicas e Biomédicas, Farmácia, Química e Física, de universidades públicas e privadas e instituições de pesquisas.
